Upstream Bio (UPB) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $11.9 million.
- Upstream Bio's Total Current Liabilities rose 950.89% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 950.89%. This contributed to the annual value of $10.7 million for FY2024, which is 6480.43% up from last year.
- As of Q3 2025, Upstream Bio's Total Current Liabilities stood at $11.9 million, which was up 950.89% from $10.9 million recorded in Q2 2025.
- Upstream Bio's 5-year Total Current Liabilities high stood at $11.9 million for Q3 2025, and its period low was $6.5 million during Q4 2023.
- Over the past 3 years, Upstream Bio's median Total Current Liabilities value was $10.8 million (recorded in 2024), while the average stood at $10.1 million.
- In the last 5 years, Upstream Bio's Total Current Liabilities soared by 6480.43% in 2024 and then surged by 950.89% in 2025.
- Over the past 3 years, Upstream Bio's Total Current Liabilities (Quarter) stood at $6.5 million in 2023, then surged by 64.8% to $10.7 million in 2024, then increased by 10.91% to $11.9 million in 2025.
- Its Total Current Liabilities was $11.9 million in Q3 2025, compared to $10.9 million in Q2 2025 and $9.6 million in Q1 2025.